Chengrong Li
- Clinical Biochemistry top 5%
- Metabolism and Genetic Disorders 9
- Infectious Diseases top 10%
-
- Streptococcal Infections and Treatments 6
-
- Coronary Artery Anomalies 4
-
- Kawasaki Disease and Coronary Complications 14
-
- High voltage insulation and dielectric phenomena 7
-
- Inflammasome and immune disorders 5
-
- Diet and metabolism studies 4
-
- Viral Infections and Immunology Research 4
Chengrong Li
64 papers receiving 598 citations
Peers
Comparison fields: 5 of 96
- Clinical Biochemistry 90
- Infectious Diseases 123
- Public Health, Environmental and Occupational Health 106
- Pulmonary and Respiratory Medicine 114
- Immunology 65
Countries citing papers authored by Chengrong Li
This map shows the geographic impact of Chengrong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengrong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengrong Li more than expected).
Fields of papers citing papers by Chengrong Li
This network shows the impact of papers produced by Chengrong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengrong Li. The network helps show where Chengrong Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chengrong Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2019 | 1 | |
| 3 | 2017 | 1 | |
| 4 | 2017 | 6 | |
| 5 | 2016 | 19 | |
| 6 | 2012 | 54 | |
| 7 | 2011 | 0 | |
| 8 | 2011 | 15 | |
| 9 | 2011 | 42 | |
| 10 | 2011 | 20 | |
| 11 | 2010 | 12 | |
| 12 | 2010 | 37 | |
| 13 | 2009 | 6 | |
| 14 | 2009 | 42 | |
| 15 | [Changes and significance for regulatory factors for signal pathways of Toll-like receptors in immunological pathogenesis of Kawasaki disease]. | 2008 | 9 |
| 16 | Preliminary Observation of Ketogenic Diet Therapy for Children with Intractable Epilepsy | 2007 | 1 |
| 17 | 2005 | 9 | |
| 18 | 2004 | 1 | |
| 19 | 2002 | 1 | |
| 20 | 1990 | 11 |
About Chengrong Li
Chengrong Li is a scholar working on Clinical Biochemistry, Immunology and Hematology, having authored 67 papers that have together received 614 indexed citations. Recurring topics across this work include Kawasaki Disease and Coronary Complications (14 papers), Metabolism and Genetic Disorders (9 papers), High voltage insulation and dielectric phenomena (7 papers), Streptococcal Infections and Treatments (6 papers), Inflammasome and immune disorders (5 papers), Diet and metabolism studies (4 papers), Coronary Artery Anomalies (4 papers) and Viral Infections and Immunology Research (4 papers). The work is most often cited by research in Clinical Biochemistry (90 citations), Infectious Diseases (123 citations) and Public Health, Environmental and Occupational Health (106 citations). Chengrong Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Guobing Wang, Jun Yang, Yuejie Zheng, Jikui Deng, Heping Wang, Ying Shen, Yonghong Yang, Xuzhuang Shen, Dezhi Cao and Yuanyuan Li. Their work appears in journals such as CHEST Journal, Pharmaceutical Research and Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.